Legal Opinion
IN RE Talis Biomedical Securities Litigation
District Court, N.D. California
Decided February 9, 2024No. 3:22-cv-00105Unknown
1Opinion
1 2 3 4 UNITED STATES DISTRICT COURT 5 NORTHERN DISTRICT OF CALIFORNIA 6 7 IN RE TALIS BIOMEDICAL Case No. 22-cv-00105-SI CORPORATION SECURITIES 8 LITIGATION, ORDER RE: PLAINTIFF’S MOTION 9 FOR CLASS CERTIFICATION 10 Re: Dkt. No. 126 11 12 13 14 On February 9, 2024, the Court held a hearing on plaintiff’s motion for class certification. 15 For the reasons set forth below, the Court GRANTS the motion. 16 17 BACKGROUND1 18 In 2022, two class actions were filed in this court on behalf of investors who purchased 19 securities of Talis Medical Corporation (“Talis”) in its February 2021 initial…
2Cases cited19 opinions
- Amchem Products, Inc. v. WindsorSupreme Court of the United States · 1997
- Wal-Mart Stores, Inc. v. DukesSupreme Court of the United States · 2011
- General Telephone Co. of Southwest v. FalconSupreme Court of the United States · 1982
- Amgen Inc. v. Connecticut Retirement Plans and Trust FundsSupreme Court of the United States · 2013
- Hanlon v. Chrysler Corp.Court of Appeals for the Ninth Circuit · 1998
14 more not listed; retrieve them via the Exa API.